Dr Tomasz Adam Murawski, MD - Medicare Anesthesiology in Boise, ID

Dr Tomasz Adam Murawski, MD is a medicare enrolled "Anesthesiology" physician in Boise, Idaho. He went to University Of California, San Diego School Of Medicine and graduated in 2006 and has 18 years of diverse experience with area of expertise as Anesthesiology. He is a member of the group practice Boise Anesthesia, P A, St Alphonsus Professional Medical Services Llc and his current practice location is 1055 N Curtis Rd, Boise, Idaho. You can reach out to his office (for appointments etc.) via phone at (208) 367-5170.

Dr Tomasz Adam Murawski is licensed to practice in Idaho (license number M-15501) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063690568.

Contact Information

Dr Tomasz Adam Murawski, MD
1055 N Curtis Rd,
Boise, ID 83706-1309
(208) 367-5170
(208) 367-5180



Physician's Profile

Full NameDr Tomasz Adam Murawski
GenderMale
SpecialityAnesthesiology
Experience18 Years
Location1055 N Curtis Rd, Boise, Idaho
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Tomasz Adam Murawski attended and graduated from University Of California, San Diego School Of Medicine in 2006
  NPI Data:
  • NPI Number: 1063690568
  • Provider Enumeration Date: 02/06/2008
  • Last Update Date: 09/29/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4385760305
  • Enrollment ID: I20210111000218

Medical Identifiers

Medical identifiers for Dr Tomasz Adam Murawski such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063690568NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207L00000XAnesthesiology A101819 (California)Secondary
207L00000XAnesthesiology M-15501 (Idaho)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Saint Alphonsus Regional Medical CenterBoise, IDHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Boise Anesthesia, P A842696064252
St Alphonsus Professional Medical Services Llc721484975158

News Archive

‘Wisdom and fear' lead 90% of U.S. seniors to covid vaccines

Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

UC researcher receives $443,000 NIH grant to study antiviral drugs

University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.

National Institute for Health Research funds for wound care research

The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.

Phase Forward's InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Tomasz Adam Murawski allows following entities to bill medicare on his behalf.
Entity NameSt Alphonsus Professional Medical Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386677524
PECOS PAC ID: 7214849751
Enrollment ID: O20040205001184

News Archive

‘Wisdom and fear' lead 90% of U.S. seniors to covid vaccines

Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

UC researcher receives $443,000 NIH grant to study antiviral drugs

University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.

National Institute for Health Research funds for wound care research

The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.

Phase Forward's InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

Read more Medical News

› Verified 4 days ago

Entity NameBoise Anesthesia, P A
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1740239599
PECOS PAC ID: 8426960642
Enrollment ID: O20041022000230

News Archive

‘Wisdom and fear' lead 90% of U.S. seniors to covid vaccines

Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

UC researcher receives $443,000 NIH grant to study antiviral drugs

University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.

National Institute for Health Research funds for wound care research

The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.

Phase Forward's InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tomasz Adam Murawski is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Tomasz Adam Murawski, MD
Po Box 7411114,
Chicago, IL 60674-1114

Ph: (208) 367-5170
Dr Tomasz Adam Murawski, MD
1055 N Curtis Rd,
Boise, ID 83706-1309

Ph: (208) 367-5170

News Archive

‘Wisdom and fear' lead 90% of U.S. seniors to covid vaccines

Amid the latest surge in covid-19 cases and hospitalizations, the United States on Tuesday hit a milestone that some thought was unattainable: 90% of people 65 and older are at least partly vaccinated against the disease.

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

UC researcher receives $443,000 NIH grant to study antiviral drugs

University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.

National Institute for Health Research funds for wound care research

The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.

Phase Forward's InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward's InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

Read more News

› Verified 4 days ago


Anesthesiology Doctors in Boise, ID

Allison Elisabeth May,
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 190 E Bannock St, Boise, ID 83712
Phone: 208-381-2222    
John Mather Hine, MD
Anesthesiology
Medicare: Not Enrolled in Medicare
Practice Location: 8800 W Emerald St, Boise, ID 83704
Phone: 208-373-5000    
Steven J Love,
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 111 W State St, Boise, ID 83702
Phone: 208-336-0895    
Dr. Timothy A Bialobrzeski, D.O.
Anesthesiology
Medicare: Accepting Medicare Assignments
Practice Location: 338 E Bannock St, Boise, ID 83712
Phone: 208-336-0895    
Brent Kenner Childers, MD
Anesthesiology
Medicare: Medicare Enrolled
Practice Location: 8800 W Emerald St, Boise, ID 83704
Phone: 208-373-5000    
Kirk A. Miller, MD
Anesthesiology
Medicare: Medicare Enrolled
Practice Location: 600 Robbins Rd, Suite 401, Boise, ID 83702
Phone: 208-489-4279    Fax: 208-424-8555

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.